MedPath

Effect of Dry needling on decreasing elbow flexor stiffness in stroke patients

Not Applicable
Conditions
chronic stroke.
Cerebral infarction, unspecified
I63.9
Registration Number
IRCT20230708058719N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

stroke-induced hemiplegia
A minimum of six months have passed since the occurrence of the stroke, indicating a chronic stage of the disease.
The degree of spasticity exhibited by the elbow flexor muscles on the affected side, as determined by the Modified Modified Ashworth Scale (MMAS), is a minimum of 1.
Age 30-75
Ability to follow instructions

Exclusion Criteria

Individuals undergoing other treatments to alleviate spasticity
The administration of pharmacological interventions aimed at reducing spasticity
Not having any contraindications to using the TMS device, such as a history of seizures, epilepsy (the person themselves or a first-degree family member), a history of head injury or brain injury, metal in the head (outside the mouth) such as surgical clips, cochlear implants, or welded parts, a history of negative reactions to MRI or TMS, a history of brain-related diseases such as MS or brain tumors, a history of fainting, or a history of severe headaches,pregnancy or conception intention within the last three months, Past use of drugs known to reduce the seizure threshold, such as imipramine, amitriptyline, doxepin, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, theophylline, phenytidine, ketamine, gamma hydroxybutyrate, amphetamine, cocaine, and recent use of drugs or alcohol

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Corticospinal excitability. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: The transcranial magnetic stimulation device is utilized to measure the resting motor threshold in elbow flexor muscles while simultaneously recording the corresponding motor-evoked potential via electromyography.;Spasticity of the elbow flexor muscles. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: Modified Modified Ashworth Scale.
Secondary Outcome Measures
NameTimeMethod
The active and passive range of motion of the elbow joint. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: The assessment will be conducted utilizing a goniometry.;Passive resistance force. Timepoint: prior to the commencement of the intervention, after three sessions of the intervention, and one week subsequent to the intervention. Method of measurement: the hand-held dynamometer.
© Copyright 2025. All Rights Reserved by MedPath